HSTMHealthcare · Health Information ServicesThe 6 Wall Street analysts covering HealthStream, Inc. hold a median 12-month price target of $36 — +10.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 89 of 100 as at 3 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores HealthStream, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (87): The share count has been shrinking and the company is not leaning on new borrowing.
Value (58): The shares cost a lot relative to the profits and assets behind them.
Size (44): Larger than most of the companies we track — more scrutinised, less often mispriced.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on HSTM, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +10.8% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Oct 2026 | Freedom Capital Markets | Initiates | Hold | $36 |
| 21 July 2026 | Canaccord Genuity | Maintains | Hold | $24 → $27 |
| 21 July 2026 | Canaccord Genuity | Maintains | Hold | — |
| 6 May 2026 | Canaccord Genuity | Maintains | Hold | — |
| 6 May 2026 | Canaccord Genuity | Maintains | Hold | $21 → $24 |
| 17 Dec 2025 | Canaccord Genuity | Maintains | Hold | — |
| 7 Aug 2025 | Canaccord Genuity | Maintains | Hold | — |
| 15 May 2025 | Canaccord Genuity | Maintains | Hold | — |
| 26 Feb 2025 | Canaccord Genuity | Maintains | Hold | — |
| 6 Feb 2025 | JMP Securities | Reiterates | Market Perform | — |
| 23 Oct 2024 | Barclays | Maintains | Overweight | — |
| 23 Oct 2024 | Canaccord Genuity | Maintains | Hold | — |
| 24 July 2024 | Canaccord Genuity | Maintains | Hold | — |
| 6 Dec 2023 | JMP Securities | Initiates | Market Perform | — |
| 22 Feb 2023 | Canaccord Genuity | Maintains | Hold | — |
| 28 Apr 2021 | Canaccord Genuity | Maintains | Hold | — |
| 28 Oct 2020 | Canaccord Genuity | Maintains | Hold | — |
| 20 Dec 2019 | Raymond James | Initiates | Market Perform | — |
| 11 July 2018 | Barrington Research | Downgrade | Market Perform | — |
| 14 June 2018 | Baird | Downgrade | Neutral | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
HSTM appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, HealthStream, Inc. returned +25.5% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 16% of US stocks
Cheaper than 39% of US stocks
Cheaper than 33% of US stocks
Cheaper than 13% of US stocks
Higher than 58% of US stocks
Higher than 62% of US stocks
Higher than 78% of US stocks
Higher than 64% of US stocks
Higher than 63% of US stocks
Higher than 55% of US stocks
Higher than 66% of US stocks
Higher than 65% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
HealthStream, Inc. has a market value of $967.1M and an enterprise value of $957.8M.
Revenue in the twelve months to 30 June 2026: $321.1M. The latest quarter grew 12.5% year on year.
Net income over the same four quarters: $21.2M, a 6.6% net margin.
Diluted earnings per share, trailing twelve months: $0.72.
Free cash flow in the twelve months to 30 June 2026: $41.6M, after $28.2M of capital spending.
HealthStream, Inc. spent $21.2M on share buybacks and $3.9M on dividends in the twelve months to 30 June 2026.
Trailing P/E: 44.4×; forward P/E: 36.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.44%, paying out 18% of earnings.
HealthStream, Inc. employs 1,139 people — $282K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own HealthStream, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
HealthStream held its third-quarter 2026 earnings conference call on November 3, 2026. The excerpt lists company executives and participating analysts but provides no financial results or management commentary.
Why it matters — HSTM watchers can note the call as a source of quarterly updates, though the provided excerpt contains no details about the company's performance.
HealthStream raised its full-year outlook after reporting 8.9% third-quarter revenue growth. Management also highlighted investments in its technology platform, bundled workforce solutions and career-network offerings.
Why it matters — The outlook increase, quarterly growth and areas of investment provide HSTM watchers with updates on the company’s performance and priorities.
HealthStream reported quarterly earnings of $0.18 per share, above the Zacks Consensus Estimate of $0.15. Earnings were $0.20 per share in the year-ago quarter.
Why it matters — HSTM watchers may note the reported earnings exceeded the consensus estimate while remaining below the year-ago per-share result.
HealthStream reported third-quarter 2026 revenue of $83.3 million, up 8.9% year over year. Operating income fell 13.0% to $6.6 million and net income declined 11.7% to $5.4 million.
Why it matters — The results show revenue growth alongside year-over-year declines in operating income and net income, providing HSTM watchers a mixed view of quarterly performance.
HealthStream announced that it will host a conference call and webcast on November 3, 2026, to discuss its third-quarter results. The company said it plans to release results after market close on November 2; the quarter ended September 30, 2026.
Why it matters — HSTM watchers can note the scheduled date for the company's third-quarter results release and discussion.
The 6 Wall Street analysts covering HealthStream, Inc. have a median 12-month price target of $36, with estimates ranging from $29 to $40. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 6 analysts covering HealthStream, Inc., 2 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks HealthStream, Inc. 89 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, HealthStream, Inc. ranks 89 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (87 of 100).
No one can know that. What the data says: the median 12-month target from 6 analysts implies +10.8% from the last close, and Ticker Nerd's factor model ranks HealthStream, Inc. 89 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering HealthStream, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HSTM are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $29 to $40 over the next 12 months.
HealthStream, Inc. returned +25.5% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
HealthStream Inc. is a healthcare technology company that provides software-as-a-service solutions for healthcare organizations in the United States.
The most recent item we track (Seeking Alpha, 3 Nov 2026): "HealthStream, Inc. (HSTM) Q3 2026 Earnings Call Transcript". HealthStream held its third-quarter 2026 earnings conference call on November 3, 2026. The excerpt lists company executives and participating analysts but provides no financial results or management commentary.
HealthStream Inc. is a healthcare technology company that provides software-as-a-service solutions for healthcare organizations in the United States. Its platform supports workforce development, learning management, credentialing, privileging, scheduling, and performance management, helping hospitals and care providers manage clinical staff more efficiently. HealthStream’s offerings also include provider enrollment and simulation-based education tools, along with modules designed to improve competency assessment and talent management across healthcare teams. The company serves hospitals, health systems, and other care delivery organizations that need integrated tools to train employees, maintain compliance, and coordinate workforce operations. HealthStream Inc. plays an important role in the healthcare information services market by connecting training, credentialing, and workforce administration within a single digital environment.
CEO Mr. Robert A. Frist Jr. · 1,139 employees · United States · https://www.healthstream.com
